Three-dimensional structure of the human breast cancer resistance protein (BCRP/ABCG2) in an inward-facing conformation.

ABCG2 is an efflux drug transporter that plays an important role in drug resistance and drug disposition. In this study, the first three-dimensional structure of human full-length ABCG2 analysed by electron crystallography from two-dimensional crystals in the absence of nucleotides and transported substrates is reported at 2 nm resolution. In this state, ABCG2 forms a symmetric homodimer with a noncrystallographic twofold axis perpendicular to the two-dimensional crystal plane, as confirmed by subtomogram averaging. This configuration suggests an inward-facing configuration similar to murine ABCB1, with the nucleotide-binding domains (NBDs) widely separated from each other. In the three-dimensional map, densities representing the long cytoplasmic extensions from the transmembrane domains that connect the NBDs are clearly visible. The structural data have allowed the atomic model of ABCG2 to be refined, in which the two arms of the V-shaped ABCG2 homodimeric complex are in a more closed and narrower conformation. The structural data and the refined model of ABCG2 are compatible with the biochemical analysis of the previously published mutagenesis studies, providing novel insight into the structure and function of the transporter.

[1]  Wen Jiang,et al.  EMAN2: an extensible image processing suite for electron microscopy. , 2007, Journal of structural biology.

[2]  J. Riordan,et al.  The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) , 2011, The Journal of Biological Chemistry.

[3]  Yue Weng,et al.  Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2009, Science.

[4]  Michael J. Hartshorn,et al.  Structural model of ATP-binding proteing associated with cystic fibrosis, multidrug resistance and bacterial transport , 1990, Nature.

[5]  Peter G. Smith,et al.  Drug Efflux Transporters and Multidrug Resistance in Acute Leukemia: Therapeutic Impact and Novel Approaches to Mediation , 2012, Molecular Pharmacology.

[6]  H. Mchaourab,et al.  Conformational cycle of the ABC transporter MsbA in liposomes: detailed analysis using double electron-electron resonance spectroscopy. , 2009, Journal of molecular biology.

[7]  Ya-li Liu,et al.  Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[8]  A Leith,et al.  SPIDER and WEB: processing and visualization of images in 3D electron microscopy and related fields. , 1996, Journal of structural biology.

[9]  S. Bates,et al.  ABCG2: a perspective. , 2009, Advanced drug delivery reviews.

[10]  Chengkun Wang,et al.  Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer , 2009, Cancer Chemotherapy and Pharmacology.

[11]  A. Barr,et al.  Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound states , 2013, Proceedings of the National Academy of Sciences.

[12]  Joe Palandra,et al.  Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe , 2008, Pharmacogenetics and genomics.

[13]  A. di Pietro,et al.  The multidrug resistance half-transporter ABCG2 is purified as a tetramer upon selective extraction from membranes. , 2010, Biochimica et biophysica acta.

[14]  A. M. George,et al.  Multidrug efflux pumps: The structures of prokaryotic ATP‐binding cassette transporter efflux pumps and implications for our understanding of eukaryotic P‐glycoproteins and homologues , 2010, The FEBS journal.

[15]  J. Schuetz,et al.  ABC transporters and their role in nucleoside and nucleotide drug resistance. , 2012, Biochemical pharmacology.

[16]  T. Litman,et al.  Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. , 2001, Cancer research.

[17]  M. Niemi,et al.  Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.

[18]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[19]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[20]  S. Bates,et al.  ABCG2: structure, function and role in drug response , 2008 .

[21]  Xiangyan Zeng,et al.  2dx_merge: data management and merging for 2D crystal images. , 2007, Journal of structural biology.

[22]  E. Boerwinkle,et al.  Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout , 2009, Proceedings of the National Academy of Sciences.

[23]  Y. Cheung,et al.  Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer. , 2005, British journal of clinical pharmacology.

[24]  H. McLeod,et al.  Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes , 2006, Investigational New Drugs.

[25]  E. Pardon,et al.  Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain , 2013, Proceedings of the National Academy of Sciences.

[26]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[27]  Y. Sugimoto,et al.  Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants , 2003, International journal of cancer.

[28]  Xiaokun Cai,et al.  Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport. , 2010, American journal of physiology. Cell physiology.

[29]  Geoffrey Chang,et al.  Flexibility in the ABC transporter MsbA: Alternating access with a twist , 2007, Proceedings of the National Academy of Sciences.

[30]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[31]  Y. Assaraf,et al.  Structure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance , 2011, PloS one.

[32]  G. Szakács,et al.  Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. , 2006, Physiological reviews.

[33]  S. Cole,et al.  Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. , 2006, Physiological reviews.

[34]  Qingcheng Mao,et al.  Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). , 2010, Current drug metabolism.

[35]  J R Kremer,et al.  Computer visualization of three-dimensional image data using IMOD. , 1996, Journal of structural biology.

[36]  A. M. George,et al.  Opening of the ADP‐bound active site in the ABC transporter ATPase dimer: Evidence for a constant contact, alternating sites model for the catalytic cycle , 2009, Proteins.

[37]  S. Bates,et al.  Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2* , 2004, Journal of Biological Chemistry.

[38]  R A Crowther,et al.  MRC image processing programs. , 1996, Journal of structural biology.

[39]  Daniel Castaño-Díez,et al.  Dynamo: a flexible, user-friendly development tool for subtomogram averaging of cryo-EM data in high-performance computing environments. , 2012, Journal of structural biology.

[40]  Z. Ni,et al.  Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP/ABCG2) that are important for transport activity and substrate specificity. , 2011, Biochemistry.

[41]  Balázs Sarkadi,et al.  Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition. , 2005, Biochimica et biophysica acta.

[42]  D. Ross,et al.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. , 2012, Biochemical pharmacology.

[43]  M. J. van de Vijver,et al.  Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. , 2001, Cancer research.

[44]  R. Dawson,et al.  Structure of a bacterial multidrug ABC transporter , 2006, Nature.

[45]  S. Bates,et al.  Towards understanding the mechanism of action of the multidrug resistance-linked half-ABC transporter ABCG2: a molecular modeling study. , 2007, Journal of molecular graphics & modelling.

[46]  R. Ford,et al.  The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantrone. , 2010, Structure.

[47]  V. Kos,et al.  The ATP-binding cassette family: a structural perspective , 2009, Cellular and Molecular Life Sciences.

[48]  A. Holzenburg,et al.  Electron crystallography of biomolecules: mysterious membranes and missing cones. , 2008, Trends in biochemical sciences.

[49]  R. Henderson,et al.  Three-dimensional structure determination by electron microscopy of two-dimensional crystals. , 1982, Progress in biophysics and molecular biology.

[50]  Willy Wriggers,et al.  Using Situs for the integration of multi-resolution structures , 2010, Biophysical Reviews.

[51]  M. Sternberg,et al.  Protein structure prediction on the Web: a case study using the Phyre server , 2009, Nature Protocols.

[52]  Honggang Wang,et al.  Membrane topology of the human breast cancer resistance protein (BCRP/ABCG2) determined by epitope insertion and immunofluorescence. , 2008, Biochemistry.

[53]  E. Hazai,et al.  Homology modeling of breast cancer resistance protein (ABCG2). , 2008, Journal of structural biology.

[54]  S. Bates,et al.  Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2. , 2010, Biochemistry.

[55]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[56]  Jue Chen,et al.  Crystal structure of the multidrug transporter P-glycoprotein from C. elegans , 2012, Nature.

[57]  W. Kühlbrandt,et al.  Surface crystallisation of the plasma membrane H+-ATPase on a carbon support film for electron crystallography. , 1999, Journal of molecular biology.

[58]  K. Linton,et al.  Structure and function of ABC transporters: the ATP switch provides flexible control , 2007, Pflügers Archiv - European Journal of Physiology.

[59]  E. Hazai,et al.  Drug transport by breast cancer resistance protein , 2010, Expert opinion on drug metabolism & toxicology.

[60]  W. O. Saxton,et al.  The correlation averaging of a regularly arranged bacterial cell envelope protein , 1982, Journal of microscopy.

[61]  S. Bates,et al.  ABCG2: determining its relevance in clinical drug resistance , 2007, Cancer and Metastasis Reviews.

[62]  Achilleas S Frangakis,et al.  Alignator: a GPU powered software package for robust fiducial-less alignment of cryo tilt-series. , 2010, Journal of structural biology.

[63]  A. M. George,et al.  Perspectives on the structure-function of ABC transporters: the Switch and Constant Contact models. , 2012, Progress in biophysics and molecular biology.